Molecular Partners Ag (MOLN) Operating Leases (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Operating Leases for 7 consecutive years, with $2.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Leases rose 212.03% year-over-year to $2.3 million in Q2 2026; TTM through Jun 2026 was $2.3 million, a 212.03% increase from a year earlier, with the FY2025 full-year figure at $2.9 million, up 110.83% from the prior year.
• Operating Leases was $2.3 million for Q2 2026 at Molecular Partners Ag, down from $2.7 million in the prior quarter.
• Over five years, Operating Leases peaked at $5.0 million in Q4 2022 and troughed at $385033.7 in Q3 2025.
• A 5-year average of $2.8 million and a median of $2.9 million in 2026 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases slumped 78.23% in 2025 and jumped 212.03% in 2026, its largest moves.
• Over 5 years, Operating Leases stood at $5.0 million in 2022, then slipped by 18.22% to $4.1 million in 2023, then tumbled by 65.98% to $1.4 million in 2024, then soared by 117.78% to $3.1 million in 2025, then retreated by 24.01% to $2.3 million in 2026.
• The last three Operating Leases figures came in at $2.3 million (Q2 2026), $2.7 million (Q1 2026), and $3.1 million (Q4 2025), per Business Quant data.